Los Angeles Capital Management LLC Acquires 380,959 Shares of UiPath Inc. (NYSE:PATH)

Los Angeles Capital Management LLC boosted its stake in shares of UiPath Inc. (NYSE:PATH - Free Report) by 53.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,096,647 shares of the healthcare company's stock after acquiring an additional 380,959 shares during the quarter. Los Angeles Capital Management LLC owned 0.19% of UiPath worth $27,241,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of PATH. Royal London Asset Management Ltd. boosted its holdings in shares of UiPath by 5.9% during the third quarter. Royal London Asset Management Ltd. now owns 139,544 shares of the healthcare company's stock worth $2,388,000 after purchasing an additional 7,742 shares during the period. O Shaughnessy Asset Management LLC bought a new stake in shares of UiPath in the 3rd quarter worth approximately $203,000. Invesco Ltd. increased its stake in shares of UiPath by 2.8% during the third quarter. Invesco Ltd. now owns 399,181 shares of the healthcare company's stock valued at $6,830,000 after buying an additional 10,863 shares during the period. California Public Employees Retirement System raised its holdings in shares of UiPath by 13.9% during the fourth quarter. California Public Employees Retirement System now owns 641,825 shares of the healthcare company's stock valued at $15,943,000 after acquiring an additional 78,459 shares in the last quarter. Finally, Symmetry Partners LLC purchased a new stake in UiPath in the fourth quarter worth $205,000. 62.50% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have commented on the stock. Morgan Stanley upped their price objective on shares of UiPath from $17.00 to $25.00 and gave the stock an "equal weight" rating in a report on Thursday, March 14th. BMO Capital Markets raised their price objective on shares of UiPath from $24.00 to $28.00 and gave the stock a "market perform" rating in a report on Thursday, March 14th. Wells Fargo & Company upped their target price on UiPath from $24.00 to $25.00 and gave the stock an "equal weight" rating in a report on Thursday, March 14th. Truist Financial restated a "buy" rating and issued a $32.00 target price on shares of UiPath in a research note on Wednesday, March 20th. Finally, TD Cowen lifted their price target on UiPath from $25.00 to $28.00 and gave the company an "outperform" rating in a research report on Thursday, March 14th. Nine analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, UiPath has an average rating of "Moderate Buy" and a consensus price target of $27.41.

UiPath Stock Performance

Shares of NYSE:PATH traded up $0.18 during midday trading on Friday, reaching $19.48. 3,862,423 shares of the company's stock traded hands, compared to its average volume of 5,757,008. UiPath Inc. has a one year low of $12.38 and a one year high of $27.87. The stock has a 50 day moving average of $21.75 and a 200 day moving average of $21.65. The company has a market cap of $11.08 billion, a price-to-earnings ratio of -114.55 and a beta of 1.01.

UiPath (NYSE:PATH - Get Free Report) last posted its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The business had revenue of $405.25 million for the quarter, compared to analysts' expectations of $383.32 million. Sell-side analysts predict that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Buying and Selling at UiPath

In related news, CFO Ashim Gupta sold 16,000 shares of the business's stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $22.84, for a total transaction of $365,440.00. Following the completion of the sale, the chief financial officer now directly owns 87,505 shares in the company, valued at $1,998,614.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders sold a total of 72,000 shares of company stock worth $1,591,360 in the last three months. 31.03% of the stock is currently owned by company insiders.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.